Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

David Archer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Endometrium

Procedures

Chemicals & Drugs

Physiology

Disorders

Uterine Hemorrhage

Concepts & Ideas

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
12
Mauck, Christine
10
Ballagh, Susan
9
Mirkin, Sebastian
5
Callahan, Marianne
5
Constantine, Ginger
5
Creinin, Mitchell
4
Baker, JM
4
Barr, SP
3
Abercrombie, Theresa
3
Creasy, George
3
Fisher, Alan
3
Brzyski, Robert
3
Grubb, Gary
3
Pymar, Helen
3
Scott, Richard

Sign-in to see all Coauthors

Publications

TOP 3
Archer David F; Pinkerton JoAnn V; Utian Wulf H; Menegoci José C; de Villiers Tobie J; Yuen Chui Kin; Levine Amy B; Chines Arkadi A; Constantine Ginger D
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.
Archer David F; Kovalevsky George; Ballagh Susan A; Grubb Gary S
Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen.
Archer David F; Lewis Vivian; Carr Bruce R; Olivier Sophie; Pickar James H
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of David Archer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Archer David F; Pinkerton JoAnn V; Utian Wulf H; Menegoci José C; de Villiers Tobie J; Yuen Chui Kin; Levine Amy B; Chines Arkadi A; Constantine Ginger D
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.
Menopause (New York, N.Y.) 2009;16(6):1109-15.
2009: Archer David F; Kovalevsky George; Ballagh Susan A; Grubb Gary S
Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen.
Contraception 2009;80(3):245-53.
2009: Archer David F; Lewis Vivian; Carr Bruce R; Olivier Sophie; Pickar James H
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women.
Fertility and sterility 2009;92(3):1039-44.
2009: Zhao Shumei; Choksuchat Chainarong; Zhao Yueqin; Ballagh Susan A; Kovalevsky George A; Archer David F
Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant.
Contraception 2009;79(6):469-78.
2009: Archer David F; Dupont Caroline M; Constantine Ginger D; Pickar James H; Olivier Sophie;
Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety.
American journal of obstetrics and gynecology 2009;200(3):238.e1-238.e10.
2009: Choksuchat Chainarong; Zhao Shumei; Deutch Todd D; Kimble Thomas D; Archer David F
Effects of progesterone, levonorgestrel and medroxyprogesterone acetate on apoptosis in human endometrial endothelial cells.
Contraception 2009;79(2):139-45.
2009: Archer David F; Seidman Larry; Constantine Ginger D; Pickar James H; Olivier Sophie
A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.
American journal of obstetrics and gynecology 2009;200(2):172.e1-10.
2009: Archer D F
Premature menopause increases cardiovascular risk.
Climacteric : the journal of the International Menopause Society 2009;12 Suppl 1():26-31.
2008: Archer David F; Philput Christine B; Levine Adam S; Cullins Vanessa; Stovall Thomas G; Bacon Janice; Weber Margaret E
Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users.
Contraception 2008;78(2):106-12.
2008: Harwood Bryna; Meyn Leslie A; Ballagh Susan A; Raymond Elizabeth G; Archer David F; Creinin Mitchell D
Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations.
American journal of obstetrics and gynecology 2008;198(1):32.e1-7.
2007: Archer David F; Hendrix Susan; Ferenczy Alex; Felix Juan; Gallagher J Chris; Rymer Janice; Skouby Sven O; den Hollander Wil; Stathopoulos Victoria; Helmond Frans A;
Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women.
Fertility and sterility 2007;88(4):866-78.
2007: Mirkin Sebastian; Archer David F
Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Maturitas 2007;57(4):338-46.
2007: Archer David F
Endometrial bleeding during hormone therapy: the effect of progestogens.
Maturitas 2007;57(1):71-6.
2007: Archer David F; Hendrix Susan; Gallagher J Chris; Rymer Janice; Skouby Sven; Ferenczy Alex; den Hollander Wil; Stathopoulos Victoria; Helmond Frans A
Endometrial effects of tibolone.
The Journal of clinical endocrinology and metabolism 2007;92(3):911-8.
2007: Archer David F
Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data.
The Journal of reproductive medicine 2007;52(2 Suppl):159-64.
2007: Archer D F
Drospirenone and estradiol: a new option for the postmenopausal woman.
Climacteric : the journal of the International Menopause Society 2007;10 Suppl 1():3-10.
2007: Archer David F
Medical decisions regarding hormone therapy for menopausal women are significantly influenced by the media.
Pharmacoepidemiology and drug safety 2007;16(1):28-31.
2006: Archer David F; Jensen Jeffrey T; Johnson Julia V; Borisute Hannah; Grubb Gary S; Constantine Ginger D
Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
Contraception 2006;74(6):439-45.
2006: Archer David F
Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives.
Contraception 2006;74(5):359-66.
2006: Mauck Christine K; Weiner Debra H; Creinin Mitchell D; Archer David F; Schwartz Jill L; Pymar Helen C; Ballagh Susan A; Henry Deborah M; Callahan Marianne M
FemCap with removal strap: ease of removal, safety and acceptability.
Contraception 2006;73(1):59-64.
2006: Mirkin S; Wong B C; Archer D F
Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():560-3.
2005: Archer David F; Thorneycroft Ian H; Foegh Marie; Hanes Vladimir; Glant Michael D; Bitterman Pincas; Kempson Richard L
Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
Menopause (New York, N.Y.) 2005;12(6):716-27.
2005: Mirkin Sebastian; Wong Benjamin C; Archer David F
Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Fertility and sterility 2005;84(2):485-91.
2005: Ronkin Sheila; Northington Robert; Baracat Edmund; Nunes Márcia G; Archer David F; Constantine Ginger; Pickar James H
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.
Obstetrics and gynecology 2005;105(6):1397-404.
2005: Archer David F
Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
Seminars in reproductive medicine 2005;23(2):188-95.
2004: Mirkin Sebastian; Archer David F
Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
Contraception 2004;70(4):327-33.
2004: Ballagh Susan A; Mauck Christine K; Henry Deborah; Archer David F; Abercrombie Theresa; Callahan Marianne M; Gabelnick Henry L
A comparison of techniques to assess cervicovaginal irritation and evaluation of the variability between two observers.
Contraception 2004;70(3):241-9.
2004: Mauck Christine K; Creinin Mitchell D; Barnhart Kurt T; Ballagh Susan A; Archer David F; Callahan Marianne M; Schmitz Susan W; Bax Richard
A phase I comparative postcoital testing study of three concentrations of C31G.
Contraception 2004;70(3):227-31.
2004: Archer David F
Neoplasia of the female reproductive tract: effects of hormone therapy.
Endocrine 2004;24(3):259-63.
2004: Mirkin Sebastian; Archer David F
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone, and 17beta-estradiol on thrombospondin-1 mRNA in Ishikawa cells.
Fertility and sterility 2004;82(1):220-2.
2004: Mauck Christine K; Weiner Debra H; Ballagh Susan A; Creinin Mitchell D; Archer David F; Schwartz Jill L; Pymar Helen C; Lai Jaim-Jou; Rencher William F; Callahan Marianne M;
Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.
Contraception 2004;70(1):77-83.
2004: Archer David F; Cullins Vanessa; Creasy George W; Fisher Alan C
The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy.
Contraception 2004;69(3):189-95.
2004: Mirkin Sebastian; Mahony Mary C; Archer David F
Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells.
Menopause (New York, N.Y.) 2004;11(1):82-8.
2004: Archer David F; Navarro Francisco J; Leslie Susan; Mirkin Sebastian
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells.
Fertility and sterility 2004;81(1):165-70.
2003: Mirkin Sebastian; Navarro Francisco; Archer David F
Hormone therapy and endometrial angiogenesis.
Climacteric : the journal of the International Menopause Society 2003;6(4):273-7.
2003: Archer David F;
Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
Menopause (New York, N.Y.) 2003;10(6):516-21.
2003: Pierson Roger A; Archer David F; Moreau Michèle; Shangold Gary A; Fisher Alan C; Creasy George W
Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.
Fertility and sterility 2003;80(1):34-42.
2003: Archer David F
Low-dose hormone therapy for postmenopausal women.
Clinical obstetrics and gynecology 2003;46(2):317-24.
2003: Navarro Francisco J; Mirkin Sebastian; Archer David F
Effect of raloxifene, 17beta-estradiol, and progesterone on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cells.
Fertility and sterility 2003;79(6):1409-15.
2002: Ballagh S A; Baker J M; Henry D M; Archer D F
Safety of single daily use for one week of C31G HEC gel in women.
Contraception 2002;66(5):369-75.
2002: Archer D F; Pickar J H
The assessment of bleeding patterns in postmenopausal women during continuous combined hormone replacement therapy: a review of methodology and recommendations for reporting of the data.
Climacteric : the journal of the International Menopause Society 2002;5(1):45-59.
2002: Archer David F; Bigrigg Alison; Smallwood Geoffrey H; Shangold Gary A; Creasy George W; Fisher Alan C
Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women.
Fertility and sterility 2002;77(2 Suppl 2):S27-31.
2001: Mauck C; Weiner D H; Ballagh S; Creinin M; Archer D F; Schwartz J; Pymar H; Lai J J; Callahan M
Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study.
Contraception 2001;64(6):383-91.
2001: Archer D F
The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women.
Menopause (New York, N.Y.) 2001;8(4):245-51.
2001: Archer D F; Dorin M; Lewis V; Schneider D L; Pickar J H
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding.
Fertility and sterility 2001;75(6):1080-7.
2000: Archer D F; Pickar J H
Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding.
Obstetrics and gynecology 2000;96(6):899-905.
2000: Tejedor A G; Doncel G F; Ballagh S A; Archer D F
Evaluation of human spermatozoa in cervical mucus: comparison of different microscopic and extraction techniques.
Contraception 2000;62(5):231-7.
2000: Kurman R J; Félix J C; Archer D F; Nanavati N; Arce J; Moyer D L
Norethindrone acetate and estradiol-induced endometrial hyperplasia.
Obstetrics and gynecology 2000;96(3):373-9.
2000: Charnock-Jones D S; Macpherson A M; Archer D F; Leslie S; Makkink W K; Sharkey A M; Smith S K
The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium.
Human reproduction (Oxford, England) 2000;15 Suppl 3():85-95.
1999: Macpherson A M; Archer D F; Leslie S; Charnock-Jones D S; Makkink W K; Smith S K
The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium.
Human reproduction (Oxford, England) 1999;14(12):3080-7.
1999: Archer D F; Mammen E F; Grubb G S
The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.
American journal of obstetrics and gynecology 1999;181(5 Pt 2):63-6.
1999: Archer D F; Maheux R; DelConte A; O'Brien F B
Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).
American journal of obstetrics and gynecology 1999;181(5 Pt 2):39-44.
1999: Archer D F; Furst K; Tipping D; Dain M P; Vandepol C
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group.
Obstetrics and gynecology 1999;94(4):498-503.
1999: Archer D F
Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free interval.
Contraception 1999;60(3):151-4.
1999: Archer D F; Dorin M H; Heine W; Nanavati N; Arce J C
Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group.
Obstetrics and gynecology 1999;94(3):323-9.
1999: Mauck C K; Callahan M M; Baker J; Arbogast K; Veazey R; Stock R; Pan Z; Morrison C S; Chen-Mok M; Archer D F; Gabelnick H L
The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.
Contraception 1999;60(1):15-24.
1999: Archer D F; DeSoto K R; Baker J M
Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. A possible mechanism of action of the intrauterine device.
Contraception 1999;59(3):175-9.
1999: Archer D F; Lobo R A; Land H F; Pickar J H
A comparative study of transvaginal uterine ultrasound and endometrial biopsy for evaluating the endometrium of postmenopausal women taking hormone replacement therapy.
Menopause (New York, N.Y.) 1999;6(3):201-8.
1998: Pickar J H; Bottiglioni F; Archer D F
Amenorrhea frequency with continuous combined hormone replacement therapy: a retrospective analysis. Menopause Study Group.
Climacteric : the journal of the International Menopause Society 1998;1(2):130-6.
1997: Pickar J H; Archer D F
Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy? Menopause Study Group (United States, Italy, Netherlands, Switzerland, Belgium, Germany, and Finland.
American journal of obstetrics and gynecology 1997;177(5):1178-83.
1997: Brzyski R G; Viniegra A; Archer D F
Suppression of luteal phase, but not midcycle, prolactin levels by chronic follicular phase opiate antagonism.
Fertility and sterility 1997;68(5):855-9.
1997: Mauck C K; Baker J M; Barr S P; Johanson W; Archer D F
A phase I study of Femcap used with and without spermicide. Postcoital testing.
Contraception 1997;56(2):111-5.
1997: Mauck C K; Allen S; Baker J M; Barr S P; Abercrombie T; Archer D F
An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9.
Contraception 1997;56(2):103-10.
1997: Mauck C K; Baker J M; Barr S P; Johanson W M; Archer D F
A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Contraception 1997;56(2):97-102.
1997: Mauck C K; Baker J M; Barr S P; Abercrombie T J; Archer D F
A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Contraception 1997;56(2):89-96.
1997: Archer D F; Maheux R; DelConte A; O'Brien F B
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).
Contraception 1997;55(3):139-44.
1996: Ramey J W; Booker S S; Kanbour-Shakir A; Campbell A E; Sharpe-Timms K L; Archer D F
Inability to establish ectopic endometrium in a natural killer cell-deficient murine model. Immunologic, histologic and histochemical assessment.
The Journal of reproductive medicine 1996;41(11):807-14.
1996: Archer D F; Philput C A; Weber M E
Management of irregular uterine bleeding and spotting associated with Norplant.
Human reproduction (Oxford, England) 1996;11 Suppl 2():24-30.
1996: Mauck C; Glover L H; Miller E; Allen S; Archer D F; Blumenthal P; Rosenzweig A; Dominik R; Sturgen K; Cooper J; Fingerhut F; Peacock L; Gabelnick H L
Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
Contraception 1996;53(6):329-35.
1995: Archer D F; Mauck C K; Viniegra-Sibal A; Anderson F D
Lea's Shield: a phase I postcoital study of a new contraceptive barrier device.
Contraception 1995;52(3):167-73.
1995: Archer D F; Fahy G E; Viniegra-Sibal A; Anderson F D; Snipes W; Foldesy R G
Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone.
American journal of obstetrics and gynecology 1995;173(2):471-7; discussion 477-8.
1994: Booker S S; Jayanetti C; Karalak S; Hsiu J G; Archer D F
The effect of progesterone on the accumulation of leukocytes in the human endometrium.
American journal of obstetrics and gynecology 1994;171(1):139-42.
1994: Ramey J W; Starke M E; Gibbons W E; Archer D F
The influence of pentoxifylline (Trental) on the antifertility effect of intrauterine devices in rats.
Fertility and sterility 1994;62(1):181-5.
1994: Archer D F
Clinical and metabolic features of desogestrel: a new oral contraceptive preparation.
American journal of obstetrics and gynecology 1994;170(5 Pt 2):1550-5.
1994: Archer D F; Pickar J H; Bottiglioni F
Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Obstetrics and gynecology 1994;83(5 Pt 1):686-92.
1994: Archer D F; Timmer C J; Lammers P
Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
Fertility and sterility 1994;61(4):645-51.
1993: Ramey J W; Archer D F
Peritoneal fluid: its relevance to the development of endometriosis.
Fertility and sterility 1993;60(1):1-14.
1993: Anderson F D; Archer D F; Harman S M; Leonard R J; Wilborn W H
Tissue response to bioerodible, subcutaneous drug implants: a possible determinant of drug absorption kinetics.
Pharmaceutical research 1993;10(3):369-80.
1992: Brzyski R G; Viniegra A; Archer D F
Effects of chronic nocturnal opiate antagonism on the menstrual cycle.
American journal of obstetrics and gynecology 1992;167(6):1780-4.
1992: Archer D F
Reversible contraception for the woman over 35 years of age.
Current opinion in obstetrics & gynecology 1992;4(6):891-6.
1991: Scott R T; Ross B; Anderson C; Archer D F
Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.
Obstetrics and gynecology 1991;77(5):758-64.
1991: Edelstein M C; Gretz J E; Bauer T J; Fulgham D L; Alexander N J; Archer D F
Studies on the in vitro spermicidal activity of synthetic magainins.
Fertility and sterility 1991;55(3):647-9.
1990: Abramowicz J S; Archer D F
Uterine endometrial peristalsis--a transvaginal ultrasound study.
Fertility and sterility 1990;54(3):451-4.
1990: Karande V C; Scott R T; Archer D F
The relationship between serum estradiol-17 beta concentrations and induced pituitary luteinizing hormone surges in postmenopausal women.
Fertility and sterility 1990;54(2):217-21.
1989: Archer D F; Hofmann G; Brzyski R; Ross B; Scott R T; Philput C B; Oehninger S; Ware J C
Effects of clomiphene citrate on episodic luteinizing hormone secretion throughout the menstrual cycle.
American journal of obstetrics and gynecology 1989;161(3):581-9; discussion 589-92.

Sign-in to see more